Characterization of a novel subset of CD8+ T cells that expands in patients receiving interleukin-12

Journal of Clinical Investigation

Volumn 102, Issue 3, 1998, Pages 561-575

  Gollob, Jared A ^a,b   Schnipper, Claudia P ^a   Orsini, Enrica ^a   Murphy, Erin ^a   Daley, John F ^a   Lazo, Suzan B ^a   Frank, David A ^a   Neuberg, Donna ^a   Ritz, Jerome ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Activation; Cancer; Cytokines; Immunotherapy; Lymphocytes

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; HELPER CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SUPPRESSOR CELL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0032146581     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI3861     Document Type: Article

References (44)

1. Chan, S.H., B. Perussia, J.W. Gupta, M. Kobayashi, M. Pospisil, H.A. Young, S.F. Wolf, D. Young, S.C. Clark, and G. Trinchieri. 1991. Induction of interferon-γ production by natural killer cell stimulatory factor: characterization of responder cells and synergy with other inducers. J. Exp. Med. 173:869-879.
2. Gately, M., B. Desai, A. Wolitzky, P. Quinn, C. Dwyer, F. Podalski, P. Familletti, F. Sinigaglia, R. Chizonnite, U. Gubler, and A. Stern. 1991. Regulation of human lymphocyte proliferation by a hetrodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J. Immunol. 147:874-882.
3. Kobayashi, M., L. Fitz, M. Ryan, R. Hewick, S. Clark, S. Chan, R. Loudon, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:827-845.
4. + T lymphocytes. J. Immunol. 151:2444-2452.
5. Robertson, M.J., R.J. Soiffer, S.F. Wolf, T.J. Manley, C. Donahue, D. Young, S.H. Herrmann, and J. Ritz. 1992. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): Cytolytic activity and proliferation of NK cells is differentially regulated by NKSF. J. Exp. Med. 175:779-788.
6. Romagnani, S. 1995. Biology of human Th1 and Th2 cells. J. Clin. Immunol. 15:121-129.
7. Trinchieri, G. 1993. Interleukin-12 and its role in the generation of Th1 cells. Immunol. Today. 14:335-338.
8. Heufler, C., F. Koch, U. Stanzl, G. Topar, M. Wysocka, G. Trinchieri, A. Enk, R.M. Steinman, N. Romani, and G. Schuler. 1996. Interleukin-12 is produced by dendritic cells and mediates T helper type 1 development as well as interferon-γ production by T helper 1 cells. Eur. J. Immunol. 26:659-668.
9. Murray, H., and J. Hariprashad. 1995. Interleukin 12 is effective treatment for an established intracellular infection: experimental visceral leishmaniasis. J. Exp. Med. 181:387-391.
10. Mountford, A., S. Anderson, and R. Wilson. 1996. Induction of Th1 cell-mediated protective immunity to Schistosoma mansoni by co-administration of larval antigens and IL-12 as adjuvant. J. Immunol. 156:4739-4745.
11. Rossol, S., G. Marinos, P. Carucci, M. Singer, R. Williams, and N. Naoumov. 1997. Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B. J. Clin. Invest. 99:3025-3033.
12. Brunda, M.J., L. Luistro, R.R. Warrier, R.B. Wright, B.R. Hubbard, M. Murphy, S.F. Wolf, and M.K. Gately. 1993. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med. 178:1223-1230.
13. Atkins, M., M. Robertson, M. Gordon, M. Lotze, M. DeCoste, J. DuBois, J. Ritz, A. Sandler, H. Edington, P. Garzone, J. Mier, C. Canning, L. Battiato, H. Tahara, and M. Sherman. 1997. Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies. Clin. Cancer Res. 3:409-417.
14. Bajetta, A., M.D. Vecchio, R. Mortarini, R. Nadeau, A. Rakhit, L. Rimassa, C. Fowst, A. Borri, A. Anichini, and G. Parmiani. 1998. Pilot study of subcutaneous recombinant human interleukin 12 in metastatic melanoma. Clin. Cancer Res. 4:75-85.
15. Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi. 1997. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science. 278:1623-1626.
16. Ogawa, M., T. Tsutsui, J.-P. Zou, J. Mu, R. Wijesuriya, W.-G. Yu, S. Herrmann, T. Kubo, H. Fujiwara, and T. Hamaoka. 1997. Enhanced induction of very late antigen 4/lymphocyte function-associated antigen 1-dependent T cell migration to tumor sites following administration of interleukin 12. Cancer Res. 57:2216-2222.
17. Yang, Y.-G., J.J. Sergio, D.A. Pearson, G.L. Szot, A. Shimizu, and M. Sykes. 1997. Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice. Blood. 90:4651-4660.
18. Sensi, M., C. Farina, C. Macalli, R. Lupetti, G. Nicolini, A. Anichini, G. Parmiani, and D. Berd. 1997. Clonal expansion of T lymphocytes in human melanoma metastases after treatment with a hapten-modified autologous tumor vaccine. J. Clin. Invest. 99:710-717.
19. Klimas, N., R. Patarca, J. Walling, R. Garcia, V. Mayer, D. Moody, T. Okarma, and M.A. Fletcher. 1994. Clinical and immunological changes in AIDS patients following adoptive therapy with activated autologous CD8 T cells and interleukin-2 infusion. AIDS. 8:1073-1081.
20. Desai, B.P., P.M. Quinn, A.G. Wolitzky, P.K.A. Mongini, R. Chizzonite, and M.K. Gately. 1992. IL-12 receptor: II. Distribution and regulation of receptor expression. J. Immunol. 148:3125-3132.
21. Chua, A.O., R. Chizzonite, B.B. Desai, T.P. Truitt, P. Nunes, L.J. Minetti, R.R. Warrier, D.H. Presky, J.F. Levine, M.K. Gately, and U. Gubler. 1994. Expression cloning of a human IL-12 receptor component: a new member of the cytokine receptor superfamily with strong homology to gp130. J. Immunol. 153:128-136.
22. Presky, D.H., H. Yang, L.J. Minetti, A.O. Chua, N. Nabavi, C.-Y. Wu, M.K. Gately, and U. Gubler. 1997. A functional interleukin 12 receptor complex is composed of two β type cytokine receptor subunits. Proc. Natl. Acad. Sci. USA. 93:14002-14007.
23. Bacon, C., E.F. Petricoin III, J. Ortaldo, R. Rees, A. Larner, J. Johnston, and J.J. O'Shea. 1995. Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc. Natl. Acad. Sci. USA. 92:7307-7311.
24. Sanders, M.E., M.W. Makgoba, S.O. Sharrow, D. Stephany, T.A. Springer, H.A. Young, and S. Shaw. 1988. Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-γ production. J. Immunol. 140:1401-1407.
25. Tough, D., P. Borrow, and J. Sprent. 1996. Induction of bystander T cell proliferation by viruses and type I Interferon in vivo. Science. 272:1947-1950.
26. Tough, D.F., S. Sun, and J. Sprent. 1997. T cell stimulation in vivo by lipopolysaccharide (LPS). J. Exp. Med. 185:2089-2094.
27. Nakarai, T., M. Robertson, M. Streuli, Z. Wu, T. Ciardelli, K. Smith, and J. Ritz. 1994. Interleukin 2 receptor γ chain expression on resting and activated lymphoid cells. J. Exp. Med. 180:241-251.
28. Gollob, J.A., J. Li, E.L. Reinherz, and J. Ritz. 1995. CD2 regulates responsiveness of activated T cells to interleukin 12. J. Exp. Med. 182:721-731.
29. Gollob, J.A., H. Kawasaki, and J. Ritz. 1997. Interferon-γ and interleukin-4 regulate T cell interleukin-12 responsiveness through the differential modulation of high affinity interleukin-12 receptor expression. Eur. J. Immunol. 27:647-652.
30. Choi, Y., B. Kotzin, L. Herron, J. Callahan, P. Marrack, and J. Kappler. 1989. Interaction of Staphylococcus aureus toxin superantigens with human T cells. Proc. Natl. Acad. Sci. USA. 86:8941-8945.
31. Puisieux, I., J. Even, C. Pannetier, F. Jotereau, M. Favrot, and P. Kourilsky. 1994. Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. J. Immunol. 153:2807-2818.
32. Claret, E., E. Alyea, E. Orsini, C. Pickett, H. Collins, Y. Wang, D. Neuberg, R. Soiffer, and J. Ritz. 1997. Characterization of T cell repertoire in patients with graft-versus leukemia after donor lymphocyte infusion. J. Clin. Invest. 100:855-866.
33. Phillips, J., and L. Lanier. 1986. Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis. J. Exp. Med. 164:814-820.
34. Caligiuri, M.A., C. Murray, M.J. Robertson, E. Wang, K. Cochran, C. Cameron, P. Schow, M.E. Ross, T.R. Klumpp, R.J. Soiffer, K.A. Smith, and J. Ritz. 1993. Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2. J. Clin. Invest. 91:123-132.
35. Kovacs, J.A., M. Baseler, R.J. Dewar, S. Vogel, J.R.T. Davey, J. Falloon, M.A. Polis, R.E. Walker, R. Stevens, N.P. Salzman, J.A. Metcalf, H. Masur, and H.C. Lane. 1995. Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. N. Engl. J. Med. 332:567-575.
36. Kovacs, J.A., S. Vogel, J.M. Albert, J. Falloon, J.R.T. Davey, R.E. Walker, M.A. Polis, K. Spooner, J.A. Metcalf, M. Baseler, G. Fyfe, H.C. Lane, R.J. Dewar, and H. Masur. 1996. Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. N. Engl. J. Med. 335: 1350-1356.
37. Bree, A.G., F.J. Schlerman, M.D. Kaviani, R.C. Hastings, S.L. Hitz, and S. Goldman. 1994. Multiple effects on peripheral hematology following administration of recombinant human interleukin 12 to nonhuman primates. Biochem. Biophys. Res. Commun. 204:1150-1157.
38. Szabo, S.J., A.S. Dighe, U. Gubler, and K.M. Murphy. 1997. Regulation of the interleukin (IL)-12R β2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185:817-824.
39. Rogge, L., L. Berberis-Maino, M. Biffi, N. Passini, D.H. Presky, U. Gubler, and F. Sinigaglia. 1997. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 185:825-831.
40. + T cells. J. Exp. Med. 186:1407-1418.
41. + memory T cells. J. Exp. Med. 186:859-865.
42. Mobley, J.L., and M.O. Daily. 1992. Regulation of adhesion molecule expression by CD8 T cells in vivo: differential regulation of gp90mel-14 (LECAM-1), Pgp-1, LFA-1, and VLA-4α during the differentiation of cytotoxic T lymphocytes induced by allografts. J. Immunol. 148:2348-2356.
43. Grabstein, K., J. Eisenman, K. Shanebeck, C. Rauch, S. Srinivasan, V. Fung, C. Beers, J. Richardson, M. Schoenborn, M. Ahdieh, L. Johnson, M. Alderson, J. Watson, D. Anderson, and J. Giri. 1994. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science. 264: 965-968.
44. Carson, W., J. Giri, M. Lindemann, M. Linett, M. Ahdieh, R. Paxton, D. Anderson, J. Eisenmann, K. Grabstein, and M. Caligiuri. 1994. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 180:1395-1403.